MIStar

Deeplink Medical has developed its offer around the MIRIO platform, which adjusts to the different use cases and needs of actors involved in medical imaging in oncology, in the clinic, and in routine. Our services rely on 3 different but complementary offers, MIRIO, a platform for the follow-up of solid tumors evaluations, and the therapeutic response of patients in oncology. The patient pathway allows a link between hospital facilities and liberal medicine. An Imaging CRO, for the follow-up of imaging data in oncological clinical trials. A scientific board supports the development of our solutions. Collaborative workflow platform structuring imaging data and radiological evaluations for patients with solid tumors allowing structuration of data in real-time (according to RECIST 1.1 and iRECIST) directly in investigation sites at the first creation of the data. Real-time evaluation of the therapeutic response of treatments according to international guidelines RECIST 1.1 and iRECIST.

BrainSightAI is a health tech company leveraging artificial intelligence and machine learning to revolutionize brain mapping through AI-based connectomics, generating personalized brain maps. Our VoxelBox products utilize AI-based connectomics to generate personalized brain maps. These tools aim to enhance pre-surgical planning and improve outcomes for patients with brain tumors and other neurological conditions. BrainSightAI collaborates with leading hospitals nationwide to conduct clinical trials focused on various brain-based disorders, including Alzheimer's disease, brain tumors, psychiatric disorders, Parkinson's disease, and stroke. Our mission is to advance brain science and enhance lives by providing cutting-edge tools for understanding the human brain.